Palo Alto Investors’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-65,620
| Closed | -$781K | – | 35 |
|
|
2023
Q3 | $781K | Hold |
65,620
| – | – | 0.07% | 27 |
|
|
2023
Q2 | $1.61M | Hold |
65,620
| – | – | 0.13% | 26 |
|
|
2023
Q1 | $2.05M | Hold |
65,620
| – | – | 0.17% | 22 |
|
|
2022
Q4 | $4.62M | Hold |
65,620
| – | – | 0.39% | 19 |
|
|
2022
Q3 | $5.65M | Hold |
65,620
| – | – | 0.45% | 21 |
|
|
2022
Q2 | $5.43M | Hold |
65,620
| – | – | 0.47% | 23 |
|
|
2022
Q1 | $10.9M | Hold |
65,620
| – | – | 0.84% | 18 |
|
|
2021
Q4 | $11M | Hold |
65,620
| – | – | 0.7% | 22 |
|
|
2021
Q3 | $5.67M | Hold |
65,620
| – | – | 0.34% | 26 |
|
|
2021
Q2 | $3.56M | Hold |
65,620
| – | – | 0.2% | 29 |
|
|
2021
Q1 | $3.91M | Buy |
65,620
+10,799
| +20% | +$644K | 0.22% | 30 |
|
|
2020
Q4 | $2.86M | Buy |
54,821
+5,889
| +12% | +$307K | 0.15% | 31 |
|
|
2020
Q3 | $2.37M | Buy |
48,932
+28,423
| +139% | +$1.38M | 0.13% | 32 |
|
|
2020
Q2 | $1.06M | Buy |
+20,509
| New | +$1.06M | 0.06% | 33 |
|